| Treatment of epidermolysis bullosa pruriginosa‐associated pruritus with dupilumab W Shehadeh, O Sarig, J Bar, E Sprecher, L Samuelov British Journal of Dermatology 182 (6), 1495-1497, 2020 | 54 | 2020 |
| Griseofulvin vs terbinafine for paediatric tinea capitis: when and for how long J Bar, L Samuelov, E Sprecher, J Mashiah Mycoses 62 (10), 949-953, 2019 | 16 | 2019 |
| Combined vaginal-cesarean delivery of twins: risk factors and neonatal outcome–a single center experience A Aviram, I Weiser, E Ashwal, J Bar, A Wiznitzer, Y Yogev The Journal of Maternal-Fetal & Neonatal Medicine 28 (5), 509-514, 2015 | 13 | 2015 |
| Evidence for cutaneous dysbiosis in dystrophic epidermolysis bullosa J Bar, O Sarig, M Lotan‐Pompan, B Dassa, M Miodovnik, A Weinberger, ... Clinical and experimental dermatology 46 (7), 1223-1229, 2021 | 10 | 2021 |
| Alopecia areata: current treatments and new directions D Dahabreh, S Jung, Y Renert-Yuval, J Bar, E Del Duca, ... American Journal of Clinical Dermatology 24 (6), 895-912, 2023 | 9 | 2023 |
| Intrapatient comparison of atopic dermatitis skin transcriptome shows differences between tape‐strips and biopsies E Del Duca, H He, Y Liu, AD Pagan, E David, J Cheng, B Carroll, ... Allergy 79 (1), 80-92, 2024 | 7 | 2024 |
| Laboratory monitoring during antifungal treatment of paediatric tinea capitis N Aleohin, J Bar, E Bar‐Ilan, L Samuelov, E Sprecher, J Mashiah Mycoses 64 (2), 157-161, 2021 | 6 | 2021 |
| Improvements in immune/melanocyte biomarkers with JAK3/TEC family kinase inhibitor ritlecitinib in vitiligo E Guttman-Yassky, E Del Duca, JC Da Rosa, J Bar, K Ezzedine, Z Ye, ... Journal of Allergy and Clinical Immunology 153 (1), 161-172. e8, 2024 | 5 | 2024 |
| Monitoring oral propranolol for infantile hemangiomata J Bar, E Bar‐Ilan, R Cleper, E Sprecher, L Samuelov, J Mashiah Dermatologic Therapy 35 (11), e15870, 2022 | 5 | 2022 |
| Pediatric Contact Dermatitis: A 10-Year Multicenter Retrospective Study D Slodownik, J Bar, M Solomon, Y Lavy, S Baum, O Mordechai Galed, ... Dermatitis® 34 (5), 399-404, 2023 | 3 | 2023 |
| Allergic contact dermatitis in the older adults: a comparative cross-sectional study D Slodownik, M Mousa, J Bar Dermatitis® 34 (4), 329-333, 2023 | 3 | 2023 |
| Intralesional human papillomavirus vaccine for the treatment of recalcitrant cutaneous warts E Bar‐Ilan, J Bar, A Baniel, D Slodownik, O Artzi, L Samuelov, E Sprecher, ... The Journal of Dermatology 50 (11), 1373-1380, 2023 | 2 | 2023 |
| Do Atopic Dermatitis Patient-Reported Outcomes Correlate With Validated Investigator Global Assessment? Insights From TARGET-AD Registry. E Guttman-Yassky, J Bar, C Lausell, L Eichenfield, A Grada, K Abuabara, ... Journal of Drugs in Dermatology: JDD 22 (4), 344-354, 2023 | 2 | 2023 |
| Diversity of atopic dermatitis and selection of immune targets C Rothenberg-Lausell, J Bar, E Del Duca, E Guttman-Yassky Annals of Allergy, Asthma & Immunology, 2023 | 1 | 2023 |
| 140 Chronic hand eczema shares a common molecular signature regardless of atopic dermatitis status J Bar, E Del Duca, E David, P Brunner, R Bissonnette, E Guttman-Yassky Journal of Investigative Dermatology 143 (11), S356, 2023 | 1 | 2023 |
| Superimposed type 2 segmental atopic dermatitis: case series and review of the literature E Bar‐Ilan, J Mashiah, R Alkalay, A Ingber, KO Zahavi, J Bar, T Zeeli, ... Clinical and Experimental Dermatology 47 (9), 1703-1706, 2022 | 1 | 2022 |
| Role of Patch Testing in Chronic Spontaneous Urticaria J Bar, S Godlewicz, A Ingber, E Sprecher, D Slodownik Journal of Asthma and Allergy, 1075-1079, 2021 | 1 | 2021 |
| Biologic and Small Molecule Therapy for Treating Moderate to Severe Atopic Dermatitis: Mechanistic Considerations C Rothenberg-Lausell, J Bar, D Dahabreh, Y Renert-Yuval, E Del Duca, ... Journal of Allergy and Clinical Immunology, 2024 | | 2024 |
| Transcriptomic evaluation of skin tape‐strips in children with allergic asthma uncovers epidermal barrier dysfunction and asthma‐associated biomarkers abnormalities E Del Duca, D Dahabreh, M Kim, J Bar, JC Da Rosa, G Rabinowitz, ... Allergy, 2024 | | 2024 |
| Identification of Risk Factors for Gliptin-associated Bullous Pemphigoid among Diabetic Patients D Shalmon, BARI Efrat, A Peled, S Geller, BAR Jonathan, N Schwartz, ... Acta Dermato-venereologica 104, 2024 | | 2024 |
